These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 15800709

  • 1. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease.
    Berstein L, Zimarina T, Kovalevskij A, Maximov S, Volkov O, Thijssen JH.
    Neoplasma; 2005; 52(2):115-8. PubMed ID: 15800709
    [Abstract] [Full Text] [Related]

  • 2. Aromatase and comparative response to its inhibitors in two types of endometrial cancer.
    Berstein L, Kovalevskij A, Zimarina T, Maximov S, Gershfeld E, Vasilyev D, Baisheva S, Baymakhasheva A, Thijssen JH.
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):71-4. PubMed ID: 15939586
    [Abstract] [Full Text] [Related]

  • 3. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [Abstract] [Full Text] [Related]

  • 4. Development and optimization of a Q-RT PCR method to quantify CYP19 mRNA expression in testis of male adult Xenopus laevis: comparisons with aromatase enzyme activity.
    Park JW, Hecker M, Murphy MB, Jones PD, Solomon KR, Van Der Kraak G, Carr JA, Smith EE, du Preez L, Kendall RJ, Giesy JP.
    Comp Biochem Physiol B Biochem Mol Biol; 2006 May; 144(1):18-28. PubMed ID: 16492402
    [Abstract] [Full Text] [Related]

  • 5. Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis.
    Hatok J, Zubor P, Galo S, Kirschnerova R, Dobrota D, Danko J, Racay P.
    Gynecol Endocrinol; 2011 May; 27(5):331-6. PubMed ID: 20553220
    [Abstract] [Full Text] [Related]

  • 6. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
    Berstein LM, Imyanitov EN, Kovalevskij AJ, Maximov SJ, Vasilyev DA, Buslov KG, Sokolenko AP, Iyevleva AG, Chekmariova EV, Thijssen JH.
    Cancer Lett; 2004 Apr 30; 207(2):191-6. PubMed ID: 15072828
    [Abstract] [Full Text] [Related]

  • 7. [Aromatase gene expression and its modifying factors in breast tumor tissue].
    Berstein LM, Larionov AA, Pauley RJ, Chernitsa OI, Semiglazov VF, Yue W, Edamatsu Kh, Ito Kh, Santen R.
    Vopr Onkol; 1999 Apr 30; 45(5):504-10. PubMed ID: 10629706
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
    Bersteĭn LM, Chernobrovkina AE, Gamaiunova VB, Vasil'ev DA, Kovalevskiĭ AIu, Maksimov SIa, Chepik OF, Gershfel'd ED.
    Vopr Onkol; 2003 Apr 30; 49(1):55-9. PubMed ID: 12715371
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aromatase expression was not detected by immunohistochemistry in endometrial cancer.
    Jeon YT, Park SY, Kim YB, Kim JW, Park NH, Kang SB, Lee HP, Song YS.
    Ann N Y Acad Sci; 2007 Jan 30; 1095():70-5. PubMed ID: 17404019
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears.
    Berstein LM, Larionov AA, Poroshina TE, Zimarina TS, Leenman EE.
    J Cancer Res Clin Oncol; 2002 Mar 30; 128(3):173-6. PubMed ID: 11935306
    [Abstract] [Full Text] [Related]

  • 15. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors.
    Bulun SE, Economos K, Miller D, Simpson ER.
    J Clin Endocrinol Metab; 1994 Dec 30; 79(6):1831-4. PubMed ID: 7989490
    [Abstract] [Full Text] [Related]

  • 16. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
    Wang Y, Man Gho W, Chan FL, Chen S, Leung LK.
    Br J Nutr; 2008 Feb 30; 99(2):303-10. PubMed ID: 17761019
    [Abstract] [Full Text] [Related]

  • 17. [Aromatase activity and its gene expression in tumor tissue of smokers and non-smokers with breast cancer].
    Berstein LM, Larionov AA, Chernitsa OI, Kolesnik OS, Manikhas AG.
    Vopr Onkol; 1998 Feb 30; 44(6):680-2. PubMed ID: 10087963
    [Abstract] [Full Text] [Related]

  • 18. [The risk of endometrial cancer appearance and CYP19 and COMT gene polymorphism].
    Szyłło K, Smolarz B, Romanowicz-Makowska H, Przybyłowska K, Lewy J, Kulig B.
    Pol Merkur Lekarski; 2007 Mar 30; 22(129):208-10. PubMed ID: 17682677
    [Abstract] [Full Text] [Related]

  • 19. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
    Sharma D, Ghai S, Singh D.
    Gen Comp Endocrinol; 2009 Jul 30; 162(3):319-28. PubMed ID: 19375426
    [Abstract] [Full Text] [Related]

  • 20. Elevated aromatase expression correlates with cervical carcinoma progression.
    Veerapaneni P, Kirma N, Nair HB, Hammes LS, Hall KL, Tekmal RR.
    Gynecol Oncol; 2009 Sep 30; 114(3):496-500. PubMed ID: 19555998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.